Roche Lifts 2021 Outlook as Delta Variant Spurs COVID-19 Test Demand
Group sales in the nine months to September rose to 46.68 billion Swiss francs ($50.54 billion) from 43.98 billion Swiss francs.
Swiss Drugmaker
Group sales in the nine months to September rose to 46.68 billion Swiss francs ($50.54 billion) from 43.98 billion Swiss francs.